Atrial Fibrillation | Norton Healthcare

Indication: Atrial Fibrillation

WATCHMAN FLX versus NOAC for EMbolic ProtectION in the Management of Patients with Non-Valvular Atrial Fibrillation

Sub-indication: Atrial Fibrillation

Study Type: Device Study

Principal Investigator: Kent Morris, M.D.
Norton Heart & Vascular Institute

Sponsor: Sponsor: Boston Scientific

Learn more at ClinicalTrials.gov

Email for more information: cvresearch@nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.